Dr. Ranjini Murthy to Join Azelis Americas as SVP of Commercial and Digital Excellence
30 Jan 2023
Executive Change
Azelis Americas announced that Dr. Ranjini Murthy is joining the company as SVP of commercial and digital excellence. In her new role, Dr. Murthy will be responsible for leading the digital strategy and commercial excellence programs for Azelis Americas. She will report to US managing director, Vuk Milojkovic.
“We are very excited for Dr. Murthy to join our leadership team,” said Milojkovic. “Her expertise and industry experience makes her an excellent choice to lead our commercial excellence and digital strategy. Digitalization is one of Azelis’ strategic pillars for growth. We sit at the forefront of digital transformation in the industry with our introduction of e-Labs, iChat, and customer portals that connect our principals and customers directly with our commercial and technical teams. Dr. Murthy will take these customer focused programs to the next level while delivering continous improvement in our sales excellence and commercial effectiveness programs which are key drivers to our growth strategy.”
Dr. Ranjini Murthy has been a leader in the chemical industry for more than 15 years. She began her career as a patent engineer at a law firm supporting chemical and oilfield clients. Murthy transitioned into the chemical industry working in different technical and commercial roles at Henkel Corporation, Air Products, Wacker, and Stepan Company.
During her time at Wacker, she was responsible for global strategy and business development driving growth in new markets. In her most recent role at Stepan, Murthy worked as the business director for the CASE, Gypsum, and Industrial Solutions (Lubricants, insulation, firefighting foams, etc.) businesses with P&L responsibility, driving sustainable growth in existing markets and strategically expanding into new markets.
“I look forward to applying all my experience in business and sales management, strategy, and market intelligence in the chemical industry to drive growth via digital strategy and commercial excellence for Azelis Americas,” Dr. Murthy said.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.